MedPath

"Juzentaihoto" for fatigue of patients with solid cancer Observational study of feasibility and safety

Not Applicable
Conditions
Fatigue in solid cancer patients
Registration Number
JPRN-UMIN000028094
Lead Sponsor
Kanazawa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1)Those who have taken Kampo formula within the last 2 weeks 2)Women who are pregnant or breast feeding 3)Person who has history of hypersensitivity to juzentaihoto 4)In case the research practitioner determines that it is inappropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility of juzentaihoto of cancer patients
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath